Liquidia Corporation Common Stock vs Sasol Ltd. American Depositary Shares — how do they compare? Liquidia Corporation Common Stock trades at $33.81 (market cap $3.04B), while Sasol Ltd. American Depositary Shares trades at $15.75 (market cap $10.06B). The key difference: Sasol Ltd. American Depositary Shares is far larger — about 3.3× Liquidia Corporation Common Stock's market cap, and Sasol Ltd. American Depositary Shares is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Sasol Ltd. American Depositary Shares for 2 Days on average.
| LQDA | SSL | |
|---|---|---|
Market Cap | $3.04B | $10.06B |
Volume | 21,111,778 | 1,082,782 |
Sector | Health | Basic Materials |
52-Week High | $91.03 | $15.63 |
52-Week Low | $22.02 | $5.33 |
Typical Hold Time | 0 Days | 2 Days |
Enterprise Value | $2.94B | $13.79B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Sasol (SSL) trades at $15.58, up 1.83% with strong technical momentum and bullish moving averages. The company shows improving fundamentals with three consecutive quarterly earnings beats and projected revenue growth from $249.1B in 2025 to $272.1B in 2026. Recent developments include a sustainable aviation fuel agreement with White Desert and board changes, while the CFO's stock sales warrant monitoring.
SSL presents a compelling value opportunity with attractive valuation multiples (P/E 13.74, EV/EBITDA 5.45) and 73% analyst buy ratings. However, risks include negative cash flow trends and high RSI levels suggesting potential overbought conditions. The stock's upside depends on continued operational improvements and commodity market stability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Sasol Limited is a Johannesburg-headquartered chemicals and energy company that uses its proprietary Fischer-Tropsch technology to convert coal, natural gas, and crude-oil feedstocks into fuels and chemical products such as polymers, solvents, surfactants, and ammonia, with operations across Southern Africa and international chemical manufacturing sites, including in US.
Read more on SSL →